Godshalk Welsh Capital Management, Inc. Abb Vie Inc. Transaction History
Godshalk Welsh Capital Management, Inc.
- $155 Million
- Q3 2024
A detailed history of Godshalk Welsh Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Godshalk Welsh Capital Management, Inc. holds 5,681 shares of ABBV stock, worth $1.01 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
5,681
Previous 5,681
-0.0%
Holding current value
$1.01 Million
Previous $974,000
15.09%
% of portfolio
0.73%
Previous 0.66%
Shares
17 transactions
Others Institutions Holding ABBV
# of Institutions
3,853Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.6 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.1 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.3MShares$9.31 Billion0.85% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.89 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $315B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...